Grant: CIHR Fellowship
Direct Payment
$150,000.00
Animal model of COMT genetic susceptibility to maternal immune activation for the development of schizophrenia-like symptoms
EF 2013-14
Résumé
Catecholamine-O-transferase (COMT) is an enzyme implicated in the degradation of catecholamines. A polymorphism in the COMT gene has been associated with developmental disorders, including schizophrenia, but these associations are relatively small, suggesting that val158met may work additively or synergistically with other common risk factors for these disorders, such as maternal infection. In this project, we will test the hypothesis that the COMT polymorphism increases reactivity to maternal infection (a well-known environmental risk factor for schizophrenia in humans), leading to a schizophrenia-like phenotype. The study will aid in our understanding of the synergistic interaction between two risk factors for schizophrenia and provide a model against which to test novel pharmacological therapies, as the ultimate goal is to prevent the onset of schizophrenia symptoms in humans carrying the COMTval158met polymorphism.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
300796
Name
Deslauriers Jessica
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Animal model of COMT genetic susceptibility to maternal immune activation for the development of schizophrenia-like symptoms
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
5-Choice Serial Reaction Task; Elisa; Fear Extinction; Genetic Model (Comt); Moy Social Preference Test; Prenatal Immune Activation; Prepulse Inhibition Of Acoustic Startle; Schizophrenia
Abstract
Catecholamine-O-transferase (COMT) is an enzyme implicated in the degradation of catecholamines. A polymorphism in the COMT gene has been associated with developmental disorders, including schizophrenia, but these associations are relatively small, suggesting that val158met may work additively or synergistically with other common risk factors for these disorders, such as maternal infection. In this project, we will test the hypothesis that the COMT polymorphism increases reactivity to maternal infection (a well-known environmental risk factor for schizophrenia in humans), leading to a schizophrenia-like phenotype. The study will aid in our understanding of the synergistic interaction between two risk factors for schizophrenia and provide a model against which to test novel pharmacological therapies, as the ultimate goal is to prevent the onset of schizophrenia symptoms in humans carrying the COMTval158met polymorphism.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Deslauriers, Jessica
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~